Inhibits bacterial protein synthesis and has antibacterial effects on Gram-positive bacteria and Chlamydia trachomatis

Erythromycin is a macrolide antibiotic whose mechanism of action is to inhibit bacterial protein synthesis. It has antibacterial effects on Gram-positive bacteria and Chlamydia trachomatis.

Erythromycin is a macrolide antibiotic whose mechanism of action is to inhibit bacterial protein synthesis. It has antibacterial effects on Gram-positive bacteria and Chlamydia trachomatis.

It promotes the synthesis and release of dopamine in the striatum, reduces the reuptake of dopamine by nerve cells, and has an anti-acetylcholine effect, thereby improving the symptoms of Parkinson's disease patients.

By inhibiting the early synthesis of bacterial cell walls, the bacterial cell wall synthesis is inhibited and leads to its death.

It interferes with bacterial folic acid metabolism and selectively inhibits the activity of bacterial dihydrofolate reductase, preventing dihydrofolate from being reduced to tetrahydrofolate, thereby preventing the synthesis of bacterial nucleic acids and proteins.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.